Cleared Traditional

K980074 - 56 SERIES AEROSOL GENERATOR

K980074 is an FDA 510(k) clearance for 56 SERIES AEROSOL GENERATOR, manufactured by Project Marketing. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 155-day FDA review.

K980074 · Project Marketing · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
155d
Days
Class 2
Risk

K980074 is an FDA 510(k) clearance for the 56 SERIES AEROSOL GENERATOR. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Project Marketing (Cary, US). The FDA issued a Cleared decision on June 12, 1998 after a review of 155 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Project Marketing devices

FDA 510(k) Submission Details - K980074

510(k) Number K980074 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 1998
Decision Date June 12, 1998
Days to Decision 155 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d slower than avg
Panel avg: 140d · This submission: 155d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 318
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K980074.
AEROTEE, MODEL # 1001
K982408 · Piper Medical Products · Sep 1998
BREATHERITE
K981944 · Ventlab Corp. · Aug 1998
STEALTH PILOT KIT/ STEALTH SPACER/FACE MASK KIT
K981167 · Dhd Healthcare Corp. · Jun 1998
3ML STERI-NEB SALINE - 0.9% W/V SODIUM CHLORIDE INHALATION SOLUTION USP
K980829 · Steripak, Ltd. · Jun 1998
HOPE NEBULIZER
K980407 · B&B Medical Technologies, Inc. · May 1998
STEALTH, METERED DOSE INHALER (MDI) SPACER WITHOUT INTEGRAL ACTUATOR
K973532 · Dhd Diemolding Healthcare Div. · Mar 1998